Ani Pharmaceuticals ANIP
NASDAQ ANIP
$70.70 +0.47 (+0.67%)
As of: Sep 9, 2026 · 3:59 PM EDT

Ani Pharmaceuticals (ANIP) Notes Payables (2010 - 2011)

Ani Pharmaceuticals' (ANIP) quarterly Notes Payables came in at $1.2 million in Q3 2011, up 3.92% quarter-over-quarter from $1.2 million in Q2 2011.

Analysis

Ani Pharmaceuticals (ANIP) Notes Payables (2010 - 2011) Analysis & Trends

Ani Pharmaceuticals has disclosed Notes Payables across 2 years of filings, most recently posting $1.2 million for Q3 2011.

  • In Q3 2011, Notes Payables changed N/A year-over-year to $1.2 million; the TTM figure through Sep 2011 stood at $1.2 million (changed N/A YoY), while the FY2010 annual figure was $1.1 million, changed N/A from the prior year.
  • Notes Payables came in at $1.2 million for Q3 2011 at Ani Pharmaceuticals, up from $1.2 million in the prior quarter.
  • In the past five years, Notes Payables ranged from a high of $1.2 million in Q3 2011 to a low of $1.1 million in Q4 2010.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 42.84 Bn 39.19 Bn 2.15 Bn
2 Viatris 19.13 Bn 18.24 Bn 1.46 Bn
3 Dr Reddys Laboratories 9.91 Bn 9.74 Bn 396.53 Mn
4 Amneal Pharmaceuticals 5.51 Bn 5.38 Bn 334.51 Mn
5 Bausch Health Companies 2.30 Bn 464.50 Mn 2.10 Bn
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn
8 Amphastar Pharmaceuticals 1.00 Bn 714.13 Mn 93.47 Mn
9 Fennec Pharmaceuticals 402.10 Mn 360.85 Mn 17.15 Mn
10 RedHill Biopharma 178.35 Mn 178.35 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2011 1.23 Mn
Jun 30, 2011 1.19 Mn
Dec 31, 2010 1.11 Mn